Literature DB >> 26571134

Pineal parenchymal tumours of intermediate differentiation - An evidence-based review of a new pathological entity.

Anthony C Amato-Watkins1, Alistair Lammie2,3, Caroline Hayhurst1, Paul Leach1.   

Abstract

Pineal region lesions are uncommon, and pineal parenchymal tumours (PPT) account for 20-30% of tumours in this area of which pineocytomas (PCs) and pineoblastomas (PBs) are more prevalent. In 2007, the World Health Organisation (WHO) reclassified PPT from two subgroups (PC and PB) into four, including pineal parenchymal tumours of intermediate differentiation (PPTID). PPTID have been further divided into low- and high-grade lesions (WHO II and III), but due to their rarity have proven difficult lesions to diagnose and a paucity of literature means their optimal treatment options are a challenge to define. This article is a review of the literature of PPTID highlighting diagnostic criteria, a discussion on the role of surgery and radiotherapy, including treatment paradigms and reported outcomes for these problematic neoplasms.

Entities:  

Keywords:  Immunohistochemistry; neoplasm; neurosurgery; radiotherapy

Mesh:

Year:  2015        PMID: 26571134     DOI: 10.3109/02688697.2015.1096912

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

Review 1.  Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades.

Authors:  Hajime Takase; Reo Tanoshima; Navneet Singla; Yoshihiko Nakamura; Tetsuya Yamamoto
Journal:  Neurosurg Rev       Date:  2021-10-20       Impact factor: 3.042

2.  Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade.

Authors:  Victor M Lu; Evan M Luther; Daniel G Eichberg; Alexis A Morell; Ashish H Shah; Ricardo J Komotar; Michael E Ivan
Journal:  J Neurooncol       Date:  2021-10-04       Impact factor: 4.130

Review 3.  Pineal Gland Tumors: A Review.

Authors:  Gaia Favero; Francesca Bonomini; Rita Rezzani
Journal:  Cancers (Basel)       Date:  2021-03-27       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.